In LSCs, aberrant CD27 expression was detected in AML and in chronic myeloid leukemia (CML), and high levels of sCD27 were associated with a poor prognosis in terms of AML [189]. This evidence concerns the gene CD27 and chronic myelogenous leukemia, BCR-ABL1 positive.